These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 38891891)
1. Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer's Disease. Bašić J; Milošević V; Djordjević B; Stojiljković V; Živanović M; Stefanović N; Aracki Trenkić A; Stojanov D; Jevtović Stoimenov T; Stojanović I Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891891 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia. Tuna G; Yener GG; Oktay G; İşlekel GH; Kİrkalİ FG J Alzheimers Dis; 2018; 66(3):1265-1273. PubMed ID: 30412498 [TBL] [Abstract][Full Text] [Related]
3. Plasma MMP-9/TIMP-1 ratio serves as a novel potential biomarker in Alzheimer's disease. Liu J; Li X; Qu J Neuroreport; 2023 Oct; 34(15):767-772. PubMed ID: 37695608 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
5. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies. Saeed U; Mirza SS; MacIntosh BJ; Herrmann N; Keith J; Ramirez J; Nestor SM; Yu Q; Knight J; Swardfager W; Potkin SG; Rogaeva E; St George-Hyslop P; Black SE; Masellis M Alzheimers Dement; 2018 Sep; 14(9):1137-1147. PubMed ID: 29782824 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease. Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419 [TBL] [Abstract][Full Text] [Related]
7. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study. Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639 [TBL] [Abstract][Full Text] [Related]
9. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. Lorenzl S; Buerger K; Hampel H; Beal MF Int Psychogeriatr; 2008 Feb; 20(1):67-76. PubMed ID: 17697439 [TBL] [Abstract][Full Text] [Related]
10. Influence of regional white matter hyperintensity volume and apolipoprotein E ε4 status on hippocampal volume in healthy older adults. Van Etten EJ; Bharadwaj PK; Hishaw GA; Huentelman MJ; Trouard TP; Grilli MD; Alexander GE Hippocampus; 2021 May; 31(5):469-480. PubMed ID: 33586848 [TBL] [Abstract][Full Text] [Related]
11. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people. Shen S; Zhou W; Chen X; Zhang J; Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-2 interactions with Alzheimer's disease biomarkers. Lane EM; Hohman TJ; Jefferson AL; Brain Imaging Behav; 2017 Dec; 11(6):1779-1786. PubMed ID: 27817134 [TBL] [Abstract][Full Text] [Related]
13. Nonlinear interaction between APOE ε4 allele load and age in the hippocampal surface of cognitively intact individuals. Martí-Juan G; Sanroma-Guell G; Cacciaglia R; Falcon C; Operto G; Molinuevo JL; González Ballester MÁ; Gispert JD; Piella G; ; Hum Brain Mapp; 2021 Jan; 42(1):47-64. PubMed ID: 33017488 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals. Aksnes M; Capogna E; Vidal-Piñeiro D; Chaudhry FA; Myrstad M; Idland AV; Halaas NB; Dakhil S; Blennow K; Zetterberg H; Walhovd KB; Watne LO; Fjell AM Neurobiol Aging; 2023 Nov; 131():11-23. PubMed ID: 37549446 [TBL] [Abstract][Full Text] [Related]
15. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease. Stomrud E; Björkqvist M; Janciauskiene S; Minthon L; Hansson O Alzheimers Res Ther; 2010 Jun; 2(3):20. PubMed ID: 20576109 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Serum Apolipoprotein B100 Combined With Hippocampal Volume in Alzheimer's Disease. Zhang D; Wu J; Ren G; Wang Y; Xu H; Chen S; Li X; Chen X Brain Behav; 2024 Oct; 14(10):e70066. PubMed ID: 39344486 [TBL] [Abstract][Full Text] [Related]
17. Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort. Teng E; Chow N; Hwang KS; Thompson PM; Gylys KH; Cole GM; Jack CR; Shaw LM; Trojanowski JQ; Soares HD; Weiner MW; Apostolova LG; Dement Geriatr Cogn Disord; 2015; 39(3-4):154-66. PubMed ID: 25547651 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study. Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]